| (SEK) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 46.75M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, XBRANE.ST returned -73.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -6.9% |
| 1 year | -73.4% |
| 5 years | -99.5% |
| 10 years | -98.2% |
| All-time high | kr 2,196.48 (Jul 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in XBRANE.ST would be worth today ›No. Xbrane Biopharma AB (publ) has not paid a dividend in the past 12 months.
Xbrane Biopharma AB (publ) is part of the Healthcare sector.
Xbrane Biopharma AB (publ) has a market cap of 195.75M SEK, based on the latest quote.
